LRRK2 and Parkinson disease: The co-occurrence of LRRK2 p.G2019S and a GBA1 mutation is a rare event (~ 2% of ~ 1400 PD patients reported in 2 recent studies [127, 128]) and seems to additively increase the risk for disease, that is the chance of developing PD in the mutant carrier [127].